Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6588)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2022 (publication date) through Apr 8, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Roth G, Teyssier Y, Benhamou M, Abousalihac M, Caruso S, Sengel C, Seror O, Ghelfi J, Seigneurin A, Ganne-Carrie N, Gigante E, Blaise L, Sutter O, Decaens T, Nault JC. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World J Gastroenterol 2022; 28(36): 5324-5337 [PMID: 36185630 DOI: 10.3748/wjg.v28.i36.5324] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Roth G, Teyssier Y, Benhamou M, Abousalihac M, Caruso S, Sengel C, Seror O, Ghelfi J, Seigneurin A, Ganne-Carrie N, Gigante E, Blaise L, Sutter O, Decaens T, Nault JC. Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World J Gastroenterol 2022; 28(36): 5324-5337 [PMID: 36185630 DOI: 10.3748/wjg.v28.i36.5324] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i36/5324.htm |
| Number | Citing Articles |
| 1 |
Jinfeng Wang, Xiaoling Wang, Xiaoran Li, Shuo Wang, Jirong Yue, Birong Dong, Ying Li. Association Between Neutrophil-to-Lymphocyte Ratio and Sarcopenia: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association 2026; 27(1): 105977 doi: 10.1016/j.jamda.2025.105977
|
| 2 |
Xuanmei Li, Xue Huang, Lifu Lei, Shiwen Tong. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1233973
|
| 3 |
Thanatchawan Polvieng, Sermsak Hongjinda, Anuparp Thienhiran, Pipit Burasakarn, Pusit Fuengfoo. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection. The American Surgeon™ 2024; 90(6): 1447 doi: 10.1177/00031348241241713
|
| 4 |
Ken Sato, Yu Miyauchi, Xinran Xu, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Tomoo Hosoe, Hiroyasu Sakai. Platinum-based anticancer drugs-induced downregulation of myosin heavy chain isoforms in skeletal muscle of mouse. Journal of Pharmacological Sciences 2023; 152(3): 167 doi: 10.1016/j.jphs.2023.04.009
|
| 5 |
Abdul Maajid Khokhar, Ayyaz Khan, Zartash Gull. Impact of Trans-Arterial Chemo-Embolization on Tumor Response in Hepatocellular Carcinoma Patients: A Retrospective Study. Pakistan BioMedical Journal 2023; : 29 doi: 10.54393/pbmj.v6i09.933
|
| 6 |
Yen-Chun Chen, Meng-Hsuan Kuo, Ching-Sheng Hsu, I-Ting Kao, Chen-Yi Wu, Chih-Wei Tseng, Shih-Chieh Shao. Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis. Cancers 2024; 16(2): 319 doi: 10.3390/cancers16020319
|
| 7 |
Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani. Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?. World Journal of Gastroenterology 2024; 30(17): 2287-2293 doi: 10.3748/wjg.v30.i17.2287
|
| 8 |
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, Anna Ludovica Fracanzani. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers 2024; 16(13): 2315 doi: 10.3390/cancers16132315
|
| 9 |
Jing Long, Xin Zhang, Wei Mi, Jianjun Shi, Hongwei Ren, Qiang Wang. The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients. Aging 2024; doi: 10.18632/aging.205375
|
| 10 |
Giorgio Esposto, Raffaele Borriello, Linda Galasso, Fabrizio Termite, Irene Mignini, Lucia Cerrito, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk. Diagnostics 2024; 14(4): 371 doi: 10.3390/diagnostics14040371
|
| 11 |
Y. Ozbay, F.G. Eldem, F. Cay, M.F. Bozkurt, B.V. Salancı, A. Ormancı, U. Aydingoz, O. Dizdar, B. Peynircioglu. Sarcopenia, myosteatosis, and skeletal muscle loss as predictors of poor prognosis in hepatocellular carcinoma patients undergoing intra-arterial therapies. Clinical Radiology 2026; 95: 107259 doi: 10.1016/j.crad.2026.107259
|
| 12 |
Ken Sato, Yoshida Satoshi, Yu Miyauchi, Fumiaki Sato, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Tomoo Hosoe, Hiroyasu Sakai. Downregulation of PGC-1α during cisplatin-induced muscle atrophy in murine skeletal muscle. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(1): 166877 doi: 10.1016/j.bbadis.2023.166877
|
| 13 |
Attapon Rattanasupar, Tanaporn Prateepchaiboon, Keerati Akarapatima, Apiradee Songjamrat, Songklod Pakdeejit, Arunchai Chang. Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70266-0
|